ALLYLANISOLE
ALLYLANISOLE is a cosmetic ingredient classified as Perfuming. Also known as CAS 140-67-0. It is regulated in 1 market including California.
Also Known As
- CAS Number
- 140-67-0
Market Overview — 29 Markets
Detailed Regulations
EuropeNo restrictions
No specific restrictions for ALLYLANISOLE in European Union, United Kingdom.
Americas1 regulation
- Chemical name
- Estragole
- CAS
- 140-67-0
- Conditions of use
- Warning required under California Proposition 65
Source: California Prop 65 (OEHHA)
East Asia & OceaniaNo restrictions
No specific restrictions for ALLYLANISOLE in South Korea, Japan, Taiwan, Australia.
ASEANNo restrictions
No specific restrictions for ALLYLANISOLE in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.
GCCNo restrictions
No specific restrictions for ALLYLANISOLE in UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain.
EAEUNo restrictions
No specific restrictions for ALLYLANISOLE in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.
Frequently Asked Questions
Is ALLYLANISOLE banned in any country?
ALLYLANISOLE is not banned in any of the 26 markets tracked by Formpli. However, it may be subject to restrictions or conditions of use in some markets.
What are the restrictions on ALLYLANISOLE in cosmetics?
ALLYLANISOLE has no specific restrictions in any of the 26 markets tracked by Formpli. It can generally be used in cosmetic formulations, subject to local general cosmetic regulations.
Can I use ALLYLANISOLE in cosmetics?
ALLYLANISOLE is regulated in 1 market. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.
Screen ALLYLANISOLE with your full formula
Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.
Check Ingredients FreeThis information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.